期刊文献+

T-AK细胞和IL-2脂质体联合硒酸酯多糖抗白血病效应的研究 被引量:17

Experimental study on antileukemia effects of anti CD3/interleukin 2 costimulated killer cells and interleukin 2 liposomes plus kappa selenocarrageenan
原文传递
导出
摘要 目的研究抗CD3单克隆抗体与IL-2共同诱导的T-AK细胞和IL-2脂质体(L-IL-2)联合硒酸酯多糖(KSC)对L1210小鼠白血病的治疗作用。方法用DBA/2小鼠建立L1210白血病模型,正常小鼠脾细胞诱生制备T-AK细胞,按设计方案转输T-AK细胞和IL-2脂质体,KSC灌胃,检测NK细胞活性、脾淋巴细胞增殖活性和IL-2诱生水平,观察荷瘤小鼠生存期。结果L1210白血病小鼠的免疫功能急剧降低,生存期为16.43±1.92天;转输T-AK细胞(5×106)和L-IL-2(104U/kg)能部分逆转白血病小鼠低下的细胞免疫功能,生存期延长(24.78±3.94天),并有14.3%小鼠长期存活;KSC(40mg/kg)对T-AK/L-IL-2的抗白血病作用有明显的增强效应,荷瘤小鼠细胞免疫功能进一步增强,生命延长率、长期存活率分别提高36%和99.9%。结论硒酸酯多糖具有生物反应调节剂(BRM)样作用;以应用T-AK细胞和IL-2脂质体为主体。 Objective To study the antileukemia and immunomodulating effect of T activated killer (T AK) cells induced by anti CD3 antibody and interleukin 2 costimulation and liposomal interleukin 2 (L IL 2) plus kappa selenocarrageenan (KSC) on L1210 leukemia mice. Methods T AK cells were induced in splenocytes from normal DBA/2 mice with anti CD3 monoclonal antibody and rIL 2.The murine L1210 leukemia model was established by ip injection of L1210 cells in DBA/2 mice, and according to the experimental protocol the L1210 bearing mice were administrated with adoptive transfer of T AK cells plus L IL 2 (T AK/L IL 2) and KSC. The cellular immune functions and the life spans of the mice were determined. Results After tumor inoculation the cellular immune functions of L1210 bearing mice decreased significantly, and their life spans were 16.43±1.92 days. Adoptively transfected T AK cells (5×10 6/mice) and L IL 2 (10 4U/kg) could partly reverse the decrease tendency of lymphocytic proliferation activity,NK cytotoxicity and IL 2 producing ability of the leukemia mice, and the survival time of the tumor bearing mice was prolonged to 24.78±3.94 days ( P <0.01), and 14.3% of the leukemic mice were cured. KSC (40mg/kg) enhanced markedly the antileukemic and immunopotentiating activities of T AK/L IL 2 therapy. The rate of life prolongation was 36%,and the cure rate of the leukemia mice was doubled. Conclusions KSC possess the activities of biological response modifier (BRM).The biotherapeutic program of T AK cells and IL 2 liposomes with adjuvant of BRM like immunocompetent potentiator KSC has great antitumor and immuno potentiating actions on murine L1210 leukemia.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 1998年第5期410-413,共4页 Chinese Journal of Microbiology and Immunology
关键词 T-AK细胞 白细胞介素2 硒酸酯多糖 白血病 T AK cells Interleukin 2 Liposomes Kappa selenocarrageenan L1210 leukemic mice Biotherapy
  • 相关文献

参考文献7

  • 1魏虎来.MTT法和LDH法检测T-AK细胞活性的研究[J].兰州医学院学报,1996,22(3):9-11. 被引量:13
  • 2魏虎来,免疫学杂志,1997年,13卷,144页
  • 3魏虎来,中华血液学杂志,1997年,18卷,243页
  • 4索金良,生理科学进展,1996年,27卷,43页
  • 5魏虎来,免疫学杂志,1995年,11卷,104页
  • 6牛桂莲,中华微生物学和免疫学杂志,1995年,15卷,86页
  • 7王文涛,中国药理学与毒理学杂志,1994年,8卷,199页

二级参考文献2

共引文献12

同被引文献236

引证文献17

二级引证文献139

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部